Dr. Reddy's Tops Billion Dollar Mark In First Nine Months Of Fiscal 2007
This article was originally published in PharmAsia News
Executive Summary
Dr. Reddy's Laboratories reported revenues exceeding $1 billion for the first time during the first nine months of fiscal 2007 (ended Dec. 31)
You may also be interested in...
Par Launches Generic Zofran ODT Following FDA Clearance
The agency also clears Dr. Reddy’s immediate-release ondansetron formulation which the Indian firm said it will launch shortly.
Indian Pharma Focusing On R&D, Licensing – Ranbaxy Exec
Indian firms are flush with cash and looking to move from generic drugs to proprietary compounds, Ranbaxy’s Shyam Bishen tells “The Pink Sheet” DAILY.
Generic Giant: Dr. Reddy’s Acquires Betapharm Group
With the $576 mil. acquisition of Betapharm, Dr. Reddy’s will expand its presence in Europe.